Unveiling the Nuances of Peripheral Neuropathy: A Vital Medical Summit in Guntur

Imagine a gathering where some of the brightest medical minds from Andhra Pradesh and Telangana converged, all with one shared mission: to shed light on a condition that often goes unnoticed, yet silently affects millions. That’s exactly what happened recently in Guntur, as the Lalitha PVS Institute of Medical Sciences kicked off its much-anticipated Lalitha CME Series, 'Advances in Peripheral Neuropathy.' It was a truly significant event, bringing together approximately 200 doctors, neurologists, and faculty members from across the two states, eager to deepen their understanding of this complex group of disorders.

The series, which launched on a Sunday, September 6, 2026, was inaugurated by Chairman P.V. Raghava Sarma, setting a collaborative tone for the day. Naren Polavarapu, the host, ensured the discussions flowed seamlessly, allowing top-tier experts to share their invaluable insights. You know, these conferences are just so crucial for keeping medical professionals up-to-date, especially when dealing with conditions that touch so many lives.

It was a sobering reminder, right from the outset: peripheral neuropathy isn't some rare ailment. Dr. Satish Khadilkar from Bombay Hospital, Mumbai, really drove this home, explaining that it impacts a noticeable 1% of the general population. But here’s the kicker – for those over 60, that figure jumps dramatically to nearly 10%. Just think about that for a moment – one in ten older adults could be living with this condition. And if you’re wondering about the biggest culprit, diabetes takes the unfortunate lead, being associated with roughly half of all peripheral neuropathy cases. It's a connection we simply can't ignore, a real public health challenge, particularly in India.

The discussions, led by esteemed speakers like Dr. P. Vijaya, Managing Director and HOD of Neurosciences, Dr. R. Muralidhar Reddy from Hyderabad, Dr. Y. Shirisha from NIMS, and Dr. Madhu Nagappa from NIMHANS, weren’t just about the well-known. They ventured into exciting, newer territory. We heard about fascinating conditions like 'nodopathies' and 'paranodopathies' – sounds complex, right? But these can actually be behind some pretty troubling symptoms: think unsteadiness when walking, tremors, and even rapid, unexplained weakness in all four limbs. It's a stark reminder that medicine is always evolving, and there’s always more to learn.

And the good news? Our diagnostic tools are getting smarter too. The doctors highlighted how modern imaging techniques are increasingly allowing us to actually see these affected nerves, which is a game-changer for accurate diagnosis. Things like MR Neurography and nerve ultrasound are truly invaluable in this regard, offering a clearer picture than ever before. Beyond the structural, there was a deep dive into immune-mediated neuropathies, exploring how our own body's defenses can sometimes go awry and target nerve tissues, creating another layer of complexity for diagnosis and treatment.

There was a palpable sense of urgency, especially when discussing diabetic neuropathy in India. The fact is, the disabilities arising from diabetes often fly under the radar here, and that needs to change. But there’s hope! The experts outlined a clear path for prevention. It boils down to a few key pillars: maintaining excellent blood sugar control – that’s paramount, of course – but also actively managing cholesterol, keeping obesity in check, tackling hypertension, and making regular exercise a non-negotiable part of daily life. Simple steps, yet profoundly impactful.

And for those already grappling with the condition, it wasn't all just prevention talk. The event explored cutting-edge treatment options, too. Spinal cord stimulation, for instance, was presented as an evidence-based neuromodulation option, offering new hope for pain relief and improved function. It's a testament to how far medical science has come, continually striving to improve patients' quality of life.

Ultimately, what resonated throughout the day was the incredible diversity of neuropathies. From those linked to infectious diseases like COVID-19, Zika, and even enteroviruses, to a myriad of other underlying issues, it’s clear that no two cases are exactly alike. This underscores the absolute necessity of a systematic, thorough approach when diagnosing and treating each patient. It’s a complex puzzle, but gatherings like this, where knowledge is shared and ideas sparked, are precisely how we move closer to solving it, one advancement at a time.